On Apr. 2, 2020, a team of scientists at Fred Hutchinson Cancer Research Center in Seattle began searching for antibodies to SARS-CoV-2 in blood samples being donated by recovered patients in Washington state and, in turn, hope to use them to either prevent or treat the disease.

Their project began back in mid-February, after researchers led by Dr. Barney Graham of the NIAID and Dr. Jason McLellan of the University of Texas posted a model of the structure of the SARS-CoV-2 spike protein. Their work was published March 13 in the journal Science.